Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial Arrhythmia
This study is currently recruiting participants.
Verified by Melbourne Health, October 2005
Sponsored by: Melbourne Health
Information provided by: Melbourne Health
ClinicalTrials.gov Identifier: NCT00232232
  Purpose

The purpose of this study is to investigate whether fish oils may be of benefit to patients with certain heart rhythm disturbances called atrial fibrillation and atrial flutter.

Atrial fibrillation and atrial flutter are two heart conditions that can be successfully treated in the hospital by an ablation (in the case of atrial flutter) or a cardioversion (in the case of atrial fibrillation). Ablation involves the application of high frequency energy waves to a particular spot in the heart. Cardioversion involves resetting the heart back to a normal rhythm with the use of an electric current.

Fish oil supplements may be of benefit to patients with heart problems. Recent evidence suggests that fish oils may benefit those with rhythm disturbances.


Condition Intervention
Atrial Fibrillation
Atrial Flutter
 Drug: Fish oil

Genetics Home Reference related topics: Brugada syndrome familial atrial fibrillation short QT syndrome
MedlinePlus related topics: Arrhythmia
Drug Information available for: Fish oil
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study

Further study details as provided by Melbourne Health:

Estimated Enrollment: 50
Study Start Date: September 2003
  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Chronic atrial flutter requiring radiofrequency ablation.
  • Chronic atrial fibrillation requiring internal cardioversion.

Exclusion Criteria:

  • Sinus rhythm.
  • Pregnancy.
  • Patients > 80 years and < 18 years of age
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00232232

Contacts
Contact: Paul Sparks, MBBS, PhD, FRACP 0393427000 ext 27133 paul.sparks@mh.org.au

Locations
Australia, Victoria
Royal Melbourne Hospital Recruiting
Melbourne, Victoria, Australia, 3050
Contact: Paul Sparks, MBBS, PhD, FRACP     0393427000 ext 27133     paul.sparks@mh.org.au    
Contact: Fiona Sutherland     0393427000 ext 27133     fiona.sutherland@mh.org.au    
Sponsors and Collaborators
Melbourne Health
Investigators
Principal Investigator: Paul Sparks Melbourne Health
  More Information

Study ID Numbers: 2003.074
Study First Received: October 2, 2005
Last Updated: June 6, 2007
ClinicalTrials.gov Identifier: NCT00232232  
Health Authority: Australia: Department of Health and Ageing Therapeutic Goods Administration

Keywords provided by Melbourne Health:
Atrial mechanical stunning and
atrial electrical remodeling

Study placed in the following topic categories:
Heart Diseases
Atrial Fibrillation
Atrial Flutter
Arrhythmias, Cardiac

Additional relevant MeSH terms:
Pathologic Processes
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009



U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services